Search Results - "Giorgi, C.A"

2.39 B-Cell Chronic Lymphocytic Leukemia Mesenchymal Stromal Cells: Implications for the Survival and Bone Marrow Localization of a Leukemic Clone by Ave, E, Frezzato, F, Gattazzo, C, Giorgi, C.A, Lessi, F, Martini, V, Trimarco, V, Cabrelle, A, Zambello, R, Facco, M, Semenzato, G, Trentin, L

Get full text

Temporal evolution of breast cancer brain metastases treatments and outcomes by Bottosso, M., Griguolo, G., Miglietta, F., Guarascio, M.C., Cattelan, A.C., Zurlo, C., Aldegheri, V., Marino, M., Zanghì, F., Giorgi, C.A., Vernaci, G., Girardi, F., Dieci, M.V., Guarneri, V.

Get full text

De-escalated therapy for HR+/HER2+ breast cancer patients with Ki67 response after 2-week letrozole: results of the PerELISA neoadjuvant study by Guarneri, V., Dieci, M.V., Bisagni, G., Frassoldati, A., Bianchi, G.V., De Salvo, G.L., Orvieto, E., Urso, L., Pascual, T., Paré, L., Galván, P., Ambroggi, M., Giorgi, C.A., Moretti, G., Griguolo, G., Vicini, R., Prat, A., Conte, P.F.

“…In human epidermal growth factor receptor 2 (HER2+) breast cancers, neoadjuvant trials of chemotherapy plus anti-HER2 treatment consistently showed lower…”
Get full text

26P Evaluation of tumor-infiltrating lymphocytes on matched baseline and residual disease samples of triple-negative breast cancer patients treated with anthracycline-taxane based neoadjuvant chemotherapy with or without carboplatin by Miglietta, F., Zarrilli, G., Massa, D., Griguolo, G., Fassan, M., Bottosso, M., Giorgi, C.A., Giarratano, T., Vernaci, G., Cesarotto, M., Guarascio, M.C., Guarneri, V., Dieci, M.V.

Get full text

140MO HER2DX genomic test in HER2-positive/hormone receptor-positive (HER2+/HR+) breast cancer (BC) treated with neoadjuvant trastuzumab (T) and pertuzumab (P): A correlative analysis from the PerELISA trial by Guarneri, V., Dieci, M.V., Griguolo, G., Pare Brunet, L., Marin, M., Miglietta, F., Bottosso, M., Giorgi, C.A., Blasco, P., Castillo, O., Galván, P., Jares, P., Puig-butille, J.A., Vivancos, A., Villagrasa Gonzalez, P., Parker, J., Perou, C.M., Conte, P.F., Prat, A.

Get full text

97P Genomic bases of endocrine sensitivity in triple-positive early breast cancer: A translational analysis of the PerELISA trial by Griguolo, G., Dieci, M.V., Bisagni, G., Frassoldati, A., Bianchi, G.V., Urso, L., Pascual, T., Pare Brunet, L., Galván, P., Giorgi, C.A., Bottosso, M., Vernaci, G., Miglietta, F., Indraccolo, S., Conte, P.F., Prat, A., Guarneri, V.

Get full text

337P Efficacy of everolimus plus exemestane in CDK 4/6 inhibitors-pretreated or naïve HR-positive/HER2-negative breast cancer patients: A secondary analysis of the EVERMET study by Nichetti, F., Marra, A., Giorgi, C.A., Randon, G., Scagnoli, S., De Angelis, C., Molinelli, C., Ferraro, E., Trapani, D., Milani, A., Agostinetto, E., Bernocchi, O., Catania, G., Rea, C.G., Basile, D., Gerratana, L., Cinausero, M., Vernieri, C.

Get full text

125P Prognostic factors in phyllodes tumours (PT) of the breast: A single-institution cohort by Di Liso, E., Bottosso, M., Tsvetkova, V., Lo Mele, M., Dieci, M.V., Falci, C., Faggioni, G., Tasca, G., Giorgi, C.A., Giarratano, T., Mioranza, E., Dei Tos, A.P., Guarneri, V., Conte, P.F.

Get full text

242P An artificial intelligence (AI)-based model to predict conversion from HER2-0 primary breast cancer (BC) to HER2-low phenotype at relapse by Miglietta, F., Collesei, A., Giarratano, T., Giorgi, C.A., Girardi, F., Cacciatore, M., Massa, D., Zanghi, F., Marino, M., Fassan, M., Dieci, M.V., Guarneri, V.

Get full text

192P - Carboplatin-containing neoadjuvant chemotherapy for triple negative breast cancer (TNBC): A propensity score-matched study by Dieci, M.V., Giorgi, C.A., Griguolo, G., Angelini, S., Miglietta, F., Giarratano, T., Falci, C., Faggioni, G., Tasca, G., Mioranza, E., Vernaci, G., Menichetti, A., Mantiero, M., Genovesi, E., Frezzini, S., Michieletto, S., Guarneri, V., Saibene, T.

“…The value of adding carboplatin (Cb) to neoadjuvant chemotherapy for TNBC is debated. Current evidence supports the association between Cb use and increased…”
Get full text

Carboplatin-containing neoadjuvant chemotherapy for triple negative breast cancer (TNBC): A propensity score-matched study by Dieci, M.V., Giorgi, C.A., Griguolo, G., Angelini, S., Miglietta, F., Giarratano, T., Falci, C., Faggioni, G., Tasca, G., Mioranza, E., Vernaci, G., Menichetti, A., Mantiero, M., Genovesi, E., Frezzini, S., Michieletto, S., Guarneri, V., Saibene, T.

Get full text

The Mini-COG as Cognitive Screening Tool in Elderly Cancer Patients: A Monoistitutional, Prospective Experience at Istituto Oncologico Veneto (IOV) by Silvestri, G., Giarratano, T., Sommacal, S., Mioranza, E., Giorgi, C.A., Serpentini, S., Ronconi, L., Bottosso, M., Barbieri, C., Guarneri, V., Falci, C.

Get full text

SIOG2022-0138 - The Mini-COG as Cognitive Screening Tool in Elderly Cancer Patients: A Monoistitutional, Prospective Experience at Istituto Oncologico Veneto (IOV) by Silvestri, G., Giarratano, T., Sommacal, S., Mioranza, E., Giorgi, C.A., Serpentini, S., Ronconi, L., Bottosso, M., Barbieri, C., Guarneri, V., Falci, C.

Get full text

168P Development of a combined clinical model to predict progression-free survival (PFS) in advanced breast cancer (ABC) treated with CDK4/6 inhibitors (CDK4/6i) by Martínez-Sáez, O., Menichetti, A., Pare Brunet, L., Griguolo, G., Rodriguez Hernandez, A., Pascual, T., Dieci, M.V., Conte, P.F., Giorgi, C.A., Brasó-Maristany, F., Chic, N., Martínez, D., Rodríguez, A., Schettini, F., Conte, B., Vidal, M., Adamo, B., Muñoz, M., Prat, A., Guarneri, V.

Get full text

211P ER-low breast cancer: Evolution from primary tumor to relapse and prognostic impact by Miglietta, F., Iannaccone, D., Griguolo, G., Giarratano, T., Porra, F., Cacciatore, M., Cappellesso, R., Girardi, F., Bottosso, M., Crema, A., Vernaci, G., Giorgi, C.A., Zurlo, C., Fassan, M., Guarneri, V., Dieci, M.V.

Get full text

Use of scalp-cooling device to prevent alopecia for breast cancer patients receiving chemotherapy: a single-Institution prospective study by Giarratano, T, Dieci, M V, Guarneri, V, Grosso, D, Zanocco, M, Faggioni, G, Falci, C, Ghiotto, C, Giorgi, C A, Griguolo, G, Mioranza, E, Pernice, G, Vernaci, G, Conte, P

Get full text